Galcanezumab

From Food & Medicine Encyclopedia

Emgality.jpg

Galcanezumab is a monoclonal antibody used for the prevention of migraine and the treatment of cluster headaches. It is marketed under the brand name Emgality. Galcanezumab works by targeting and inhibiting the activity of calcitonin gene-related peptide (CGRP), a molecule involved in the pathophysiology of migraine.

Medical Uses[edit]

Galcanezumab is primarily used for:

Mechanism of Action[edit]

Galcanezumab is a humanized monoclonal antibody that binds to CGRP, a neuropeptide that plays a crucial role in the transmission of pain and the dilation of blood vessels in the brain. By inhibiting CGRP, galcanezumab helps to reduce the frequency and severity of migraine attacks and cluster headaches.

Administration[edit]

Galcanezumab is administered via subcutaneous injection. The typical dosage for migraine prevention is an initial loading dose followed by monthly maintenance doses. For cluster headaches, the dosage and frequency may vary based on the severity and frequency of the attacks.

Side Effects[edit]

Common side effects of galcanezumab include:

Serious side effects are rare but may include hypersensitivity reactions.

History[edit]

Galcanezumab was developed by Eli Lilly and Company. It received approval from the U.S. Food and Drug Administration (FDA) for the prevention of migraine in September 2018 and for the treatment of episodic cluster headaches in June 2019.

Research[edit]

Ongoing research is exploring the potential of galcanezumab in treating other types of headaches and pain conditions. Clinical trials are also investigating its long-term safety and efficacy.

See Also[edit]

References[edit]

External Links[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.